This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: BKW CMG HP MCD PNRA


(AKRX) was downgraded at Leerink Swann to market perform from outperform. Valuation call, based on a 12-month price target of $25, Leerink Swann said.

Baker Hughes (BHI) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $60. Margin growth is likely to be slower than expected, RBC Capital said.

Burger King (BKW) was initiated at UBS with a buy rating. Refinancing of expensive notes and conversion to a high- free cash, high-yielding stock is underappreciated, UBS said. Twelve-month price target is $26.

Buffalo Wild Wings (BWLD) was initiated at UBS with a buy rating. Momentum in core brand sales and AUVs, UBS said. Twelve-month price target is $165.

Citigroup (C) was initiated at Jefferies with a hold rating. Revenue diversification and accelerated capital creation through DTA recapture, Jefferies said. But consensus EPS forecasts look high, Jefferies also said. Twelve-month price target is $60.

Cardinal Health (CAH) was downgraded at J.P. Morgan to neutral from overweight. Valuation call, as the stock gained 60% in 2013, J.P. Morgan said.

Cameron (CAM) was downgraded at RBC Capital to outperform from Top Pick. Valuation call, based on a twelve-month price target of $68, RBC Capital said.

Crown Holdings (CCK) was upgraded at J.P. Morgan to overweight. Twelve-month price target is $52. Expect the Mivisa deal to be approved, with minimal earnings impact, J.P. Morgan said.

Clorox (CLX) was downgraded at J.P. Morgan to underweight from neutral. Valuation call, as the stock is trading with a forward price-to-earnings multiple of 20.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CMG $639.79 -0.62%
MCD $96.82 0.39%
AAPL $130.40 -1.70%
FB $80.74 -1.40%
GOOG $553.67 -0.31%


DOW 18,110.14 +72.17 0.40%
S&P 500 2,114.76 +5.84 0.28%
NASDAQ 5,055.4220 -4.8240 -0.10%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs